Flerie AB
- BID
1.875
- ASK
1.925
- 676 Units1,039 Units
- 07/17, 21:58:33 PM
Sector and Industry
Finance, Investment Services
Performance (1Y)
47.61%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.77 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Morgan Stanley | 239.26 Bil. | 106.12 Bil. | 17.39 | +20.74 % | 0.00 | - |
| Goldman Sachs Group Inc | 221.89 Bil. | 111.88 Bil. | 17.13 | +15.36 % | 0.00 | - |
| Citigroup Inc | 173.63 Bil. | 149.94 Bil. | 16.69 | +8.33 % | 0.00 | - |
| Blackstone Inc. | 161.27 Bil. | 12.10 Bil. | 39.83 | +4.26 % | 0.00 | - |
| Charles Schwab Corp. | 149.58 Bil. | 24.53 Bil. | 21.47 | +42.84 % | 0.00 | - |
| Blackrock Inc. | 148.69 Bil. | 22.09 Bil. | 30.31 | -16.40 % | 0.00 | - |
| UBS Group | 122.81 Bil. | 70.13 Bil. | 18.06 | +46.64 % | 0.00 | - |
| KKR & Co. Inc. | 96.76 Bil. | 18.24 Bil. | 54.43 | -26.12 % | 0.00 | - |
| Investor AB ser. B | 93.48 Bil. | 7.58 Bil. | 6.43 | +43.87 % | 0.00 | - |
| Investor AB ser. A | 93.00 Bil. | 7.58 Bil. | 6.39 | +43.87 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1.875 G | 0 Units |
| PRICE DETERMINATION TIME | 07/17/2026 / 09:56:58 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 1.875 | 1.77 |
| PREV. DAY'S PRICE | 1.88 | (07/16) |
| CHANGE DAY BEFORE | -0.00 | -0.27 % |
| 52 WEEK HIGH / LOW | 3.4213 (07/18) | 1.685 (06/24) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -1.37 | -0.25 | -0.77 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 0.57 | 0.87 | 0.86 | - | - |
PRICE - SALES RATIO | 1.40 | 33,086.16 | 173.77 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A40H89 |
| ISIN | SE0022447348 |
| SYMBOL | 1NP1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | FLERIE AB |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Finance, Investment Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.59 % | 3.02 % | -15.97 % | -36.79 % | -47.61 % | -49.46 % | -83.96 % | -37.62 % |
| HIGH | 1.88 | 1.94 | 2.46 | 3.01 | 3.42 | 287.00 | 287.00 | 3.05 |
| LOW | 1.77 | 1.69 | 1.69 | 1.69 | 1.69 | 0.35 | 0.35 | 1.69 |
Dividende
pro Aktie
FLERIE AB does not deliver dividend information
Company profile
Flerie AB is a long-term life science investor focusing on biotech and pharmaceutical investments globally. The company operates through the following segments: Product Development, Commercial Growth, and Limited Partnerships. The Product Development segment focuses on advancing biotech and pharmaceutical innovations from concept to market readiness. The Commercial Growth segment drives expansion and revenue generation for existing products and portfolio companies. The Limited Partnerships segment manages investments through strategic partnerships with other industry players. The company was founded by Thomas Eldered in 2011 and is headquartered in Stockholm, Sweden.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.